AIM ImmunoTech Inc. (AIM) Financials

$0.14

south_east
-$0 (-1.47%)
Day's range
$0.14
Day's range
$0.14
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25M-$30M-$30MEarning201720172018201820192019202020202021202120222022202320230%0%-5000%-5000%-10000%-10000%-15000%-15000%-20000%-20000%-25000%-25000%-30000%-30000%-35000%-35000%Profit Margin
Profit Margin
Revenue
Earnings

AIM Income statement / Annual

Last year (2023), AIM ImmunoTech Inc.'s total revenue was $202,000.00, an increase of 43.26% from the previous year. In 2023, AIM ImmunoTech Inc.'s net income was -$28.96 M. See AIM ImmunoTech Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $202,000.00 $141,000.00 $135,000.00 $163,000.00 $140,000.00 $367,000.00 $437,000.00 $92,000.00 $133,000.00 $197,000.00
Cost of Revenue $42,000.00 $19.92 M $850,000.00 $806,000.00 $893,000.00 $884,000.00 $1.18 M $1.11 M $1.60 M $1.25 M
Gross Profit $160,000.00 -$19.78 M -$715,000.00 -$643,000.00 -$753,000.00 -$517,000.00 -$746,000.00 -$1.02 M -$1.47 M -$1.05 M
Gross Profit Ratio 0.79 -140.3 -5.3 -3.94 -5.38 -1.41 -1.71 -11.04 -11.02 -5.35
Research and Development Expenses $10.94 M $6.99 M $7.67 M $5.72 M $4.65 M $4.78 M $4.10 M $5.11 M $8.04 M $8.99 M
General & Administrative Expenses $21.14 M $13.07 M $8.67 M $8.65 M $7.04 M $6.20 M $6.57 M $7.68 M $7.15 M $9.06 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $21.14 M $13.07 M $8.67 M $8.65 M $7.04 M $6.20 M $6.57 M $7.68 M $7.15 M $9.06 M
Other Expenses $0.00 $1.49 M $2.32 M $1.19 M $866,000.00 $277,000.00 $3.21 M $2.87 M $1.37 M $1.13 M
Operating Expenses $32.08 M $20.06 M $16.34 M $14.37 M $11.69 M $10.98 M $10.67 M $12.79 M $15.19 M $18.05 M
Cost And Expenses $32.12 M $20.06 M $17.19 M $15.18 M $12.58 M $11.86 M $11.85 M $13.90 M $16.78 M $19.30 M
Interest Income $0.00 $629,000.00 $67,000.00 $219,000.00 $89,000.00 $46,000.00 $88,000.00 $129,000.00 $364,000.00 $665,000.00
Interest Expense $0.00 $0.00 $67,000.00 $672,000.00 $427,000.00 $502,000.00 $139,000.00 $129,000.00 $3,000.00 $11,000.00
Depreciation & Amortization $238,000.00 -$424,000.00 $805,000.00 $706,000.00 $829,000.00 $920,000.00 $1.00 M $1.17 M $1.19 M $1.14 M
EBITDA -$31.68 M -$19.87 M -$18.26 M -$13.02 M -$8.15 M -$8.41 M -$7.12 M -$6.33 M -$14.25 M -$16.74 M
EBITDA Ratio -156.82 -124.45 -103.44 -79.01 -76.4 -28.05 -16.27 -134.48 -113.5 -87.78
Operating Income Ratio -158 -141.3 -139.54 -92.96 -88.88 -31.32 -26.12 -150.04 -125.19 -96.95
Total Other Income/Expenses Net $2.95 M $478,000.00 -$289,000.00 $752,000.00 $3.04 M $1.67 M $3.16 M $6.30 M $1.42 M $1.65 M
Income Before Tax -$28.96 M -$19.45 M -$19.13 M -$14.40 M -$9.53 M -$9.81 M -$8.26 M -$7.50 M -$15.23 M -$17.45 M
Income Before Tax Ratio -143.38 -137.91 -141.68 -88.34 -68.09 -26.74 -18.9 -81.54 -114.51 -88.58
Income Tax Expense $0.00 $1.64 M $2.39 M $1.86 M $1.29 M $2.19 M $3.35 M $134,000.00 $3,000.00 $11,000.00
Net Income -$28.96 M -$21.09 M -$21.51 M -$16.26 M -$10.83 M -$9.81 M -$8.26 M -$7.50 M -$15.23 M -$17.45 M
Net Income Ratio -143.38 -149.55 -159.36 -99.74 -77.33 -26.74 -18.9 -81.54 -114.51 -88.58
EPS -0.6 -0.44 -0.45 -0.51 -2.97 -9.77 -12.67 -15.13 -34.05 -48.93
EPS Diluted -0.6 -0.44 -0.45 -0.51 -2.97 -9.77 -12.67 -15.13 -34.05 -48.93
Weighted Average Shares Out $48.59 M $48.05 M $47.34 M $31.84 M $3.64 M $1.00 M $651,721.00 $495,862.00 $447,251.00 $356,609.00
Weighted Average Shares Out Diluted $48.59 M $48.05 M $47.34 M $31.84 M $3.64 M $1.00 M $651,721.00 $495,862.00 $447,251.00 $356,609.00
Link